The global market for infection surveillance solutions is set for substantial expansion, with projections estimating an increase from $544.93 million in 2022 to approximately $1,581.37 million by 2031 — a compound annual growth rate (CAGR) of 12.7%. This substantial growth is primarily fueled by the escalating prevalence of hospital-acquired infections (HAIs) and the amplifying integration of advanced IT systems in healthcare environments.
InsightAce Analytic Pvt. Ltd.’s market report provides a comprehensive analysis of the global infection surveillance solutions market. It dissects elements like product and services varieties, end-users, as well as industry trends, competition analysis, and forecasted revenues until 2031. According to the firm’s research, the global market is expected to witness a substantial CAGR of 12.7% for the forecast period of 2023-2031.
The essence of infection surveillance solutions lies in aiding healthcare professionals in data collection, analysis, and interpretation relating to patient infections. These technological solutions have efficiently heightened the standard of patient care by ensuring real-time monitoring of data and helping in diagnostic processes, particularly with antibiotic-resistant organisms (AROs), and preventing numerous conditions, including ventilator-associated pneumonia, urinary tract infections, surgical infections, and central line blood infections.
The market’s growth trajectory is further stimulated by a combination of factors such as the rampant rise in hospital-acquired infections (HAIs) and global efforts to enhance patient safety, particularly through improved quality of care and stringent measures for HAI prevention. Coupled with the increasing cost of healthcare and the augmented adoption rate of new IT systems in hospitals, particularly for maintaining electronic healthcare records (EHR), these factors are forecasted to drive the expansion of this market.
Key players steering the current market trends include the rise in hospital-acquired infections worldwide, the prevalent disinterest in optimizing hygiene standards in healthcare facilities, and the escalating healthcare costs. Furthermore, the growing preference of automation in healthcare facilities and the increasing demand for web-based and mobile platforms represent crucial trends in the infection surveillance solutions market. However, challenges such as the steep cost of software, reluctance from medical professionals to adopt innovative products, and a lack of trained professionals may hinder market growth.
Region-wise, North America is predicted to dominate the infection surveillance solutions market in terms of revenue, due to the urgent necessity to reduce HAIs and widespread expansion of medical institutions. Major players providing cutting-edge on-premise and web-based software also contribute to the region’s market growth. Asia-Pacific is not far behind, with heightened access to advanced medical facilities, rapid improvement in health insurance industries, climbing healthcare costs, and the growing prevalence of HAIs setting a fertile ground for market prosperity.
The market is both segmented and analyzed based on product and services, end-users, and regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.